En bloc resection of bladder tumor has recently emerged as an alternative to TURBT aiming to improve surgical quality and pathological assessment.

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association ...

A phase 2 trial evaluated the effectiveness and safety of neoadjuvant intravesical mitomycin-C instillation in patients with urothelial non-muscle invasive bladder cancer.

The earliest indicator of bladder cancer is the presence of blood in the urine. At later stages, the illness may be ...

The phase 2, single-arm INDIBLADE trial assessed induction ipilimumab plus nivolumab followed by CRT in patients with MIBC.

Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that China's National Medical Products ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small ...

The girl underwent a single-stage surgery with a team that involved orthopedics, plastic surgery, and neurosurgery. Resection ...

Detailed price information for Usana Health Sciences Inc (USNA-N) from The Globe and Mail including charting and trades.

Oncology Media Relations   Oncology_media_relations@its.jnj.com     Investor contact: Jess Margevich investor-relations@its.jnj.com ...

Results with Optilume consistent in clinical trials and real world, regardless of prostate ...

When someone is diagnosed with colorectal cancer—which includes both colon and rectal cancers—many people immediately think ...